Resveratrol alters microRNA expression profiles in A549 human non-small cell lung cancer cells

Molecules and Cells

Volumn 32, Issue 3, 2011, Pages 243-249

  Bae, Seunghee ^a   Lee, Eun Mee ^a   Cha, Hwa Jun ^a   Kim, Karam ^a   Yoon, Yeongmin ^a   Lee, Hyunjin ^a   Kim, Jongran ^a   Kim, Yu Jeong ^b   Lee, Hong Ghi ^c   Jeung, Hoi Kyung ^d   Min, Yoo Hong ^d   An, Sungkwan ^a  

^a Konkuk University   (South Korea)

^b Yeoju Institute of Technology   (South Korea)

^c Konkuk University Hospital   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

A549; Human non small cell lung cancer cells; MicroRNA; Resveratrol

Indexed keywords

MICRORNA; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE IDENTIFICATION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STILBENES;

EID: 84855655200     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-011-1037-z     Document Type: Article

References (40)

1. Aggarwal, B.B., Bhardwaj, A., Aggarwal, R.S., Seeram, N.P., Shishodia, S., and Takada, Y. (2004). Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res. 24, 2783-2840. (Pubitemid 39409568)
2. Ambros, V., and Chen, X. (2007). The regulation of genes and genomes by small RNAs. Development 134, 1635-1641. (Pubitemid 46796561)
3. Ambros, V., and Lee, R.C. (2004). Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol. Biol. 265, 131-158.
4. Bartel, D.P. (2004). MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
5. Bhat, K.P., and Pezzuto, J.M. (2002). Cancer chemopreventive activity of resveratrol. Ann. N. Y. Acad. Sci. 957, 210-229. (Pubitemid 34721666)
6. Bhat, K.P.L., Kosmeder, J.W.2nd., and Pezzuto, J.M. (2001). Biological effects of resveratrol. Antioxid. Redox. Signal. 3, 1041-1064. (Pubitemid 34027361)
7. Calin, G.A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S.E., Iorio, M.V., Visone, R., Sever, N.I., Fabbri, M., et al. (2005). A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353, 1793-1801. (Pubitemid 41549891)
8. Chen, J.F., Mandel, E.M., Thomson, J.M., Wu, Q., Callis, T.E., Hammond, S.M., Conlon, F.L., and Wang, D.Z. (2006). The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38, 228-233. (Pubitemid 43177239)
9. Cheng, A.M., Byrom, M.W., Shelton, J., and Ford, L.P. (2005). Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 33, 1290-1297. (Pubitemid 41439922)
10. Cho, W.J., Shin, J.M., Kim, J.S., Lee, M.R., Hong, K.S., Lee, J.H., Koo, K.H., Park, J.W., and Kim, K.S. (2009). miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2. Mol. Cells 28, 521-527.
11. Delmas, D., Jannin, B., and Latruffe, N. (2005). Resveratrol: Preventing properties against vascular alterations and ageing. Mol. Nutr. Food. Res. 49, 377-395. (Pubitemid 40780387)
12. Eder, M., and Scherr, M. (2005). MicroRNA and lung cancer. N. Engl. J. Med. 352, 2446-2448. (Pubitemid 40958446)
13. Faber, A.C., and Chilles, T.C. (2006). Resveratrol induces apoptosis in transformed follicular lymphoma OCI-LY8 cells: Evidence for a novel mechanism involving inhibition of BCL6 signaling. Int. J. Oncol. 29, 1561-1566.
14. Guo L., and Lu, Z. (2010). The fate of miRNA* strand through Evolutionary anlysis: Implication for degradation as carrier strand or potential regulatory molecules? PLoS One 5, e11387
15. He, L., Thomson, J.M., Hemann, M.T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S.W., Hannon, G.J., et al. (2005). A microRNA polycistron as a potential human oncogene. Nature 435, 828-833. (Pubitemid 40839734)
16. John, B., Enright, A.J., Aravin, A., Tuschl, T., Sander, C., and Marks, D.S. (2004). Human MicroRNA targets. PLoS Biol. 2, e363.
17. Johnson, S.M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K.L., Brown, D., and Slack, F.J. (2005). RAS is regulated by the let-7 microRNA family. Cell 120, 635-647. (Pubitemid 40343076)
18. Kasdallah-Grissa, A., Mornagui, B., Aouani, E., Hammami, M., El May, M., Gharbi, N., Kamoun, A., and El-Fazaa, S. (2007). Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. Life Sci. 80, 1033-1039. (Pubitemid 46204723)
19. Kim, Y.A., Lee, W.H., Choi, T.H., Rhee, S.H., Park, K.Y., and Choi, Y.H. (2003). Involvement of p21WAF1/CIP1, pRB, Bax and NFkappaB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells. Int. J. Oncol. 23, 1143-1149.
20. Kundu, J.K., and Surh, Y.J. (2004). Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat. Res. 555, 65-80. (Pubitemid 39345398)
21. Logarajah, S., Hunter, P., Kraman, M., Steele, D., Lakhani, S., Bobrow, L., Venkitaraman, A., and Wagner, S. (2003). BCL-6 is expressed in breast cancer and prevents mammary epithelial differentiation. Oncogene 22, 5572-5578. (Pubitemid 37102692)
22. Ma, X.D., Yan, F., Ma, A.D., and Wang, H.J. (2006). Resveratrol induces HepG2 cell apoptosis by depolarizing mitochondrial membrane. Nan Fang Yi Ke Da Xue Xue Bao 26, 406-408
23. Matsuoka, A., Furuta, A., Ozaki, M., Fukuhara, K., and Miyata, N. (2001). Resveratrol, a naturally occurring polyphenol, induces sister chromatid exchanges in a Chinese hamster lung (CHL) cell line. Mutat. Res. 494, 107-113. (Pubitemid 32566287)
24. Moammir, H.A., Minakshi, N., Vivian, X.F., David, F.J., and Nihal, A. (2006). Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins. Mol. Cancer Ther. 5, 1335-1341.
25. Mollerup, S., Ovrebo, S., and Haugen, A. (2001). Lung carcinogenesis: Resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells. Int. J. Cancer 92, 18-25. (Pubitemid 32187027)
26. Nana-Sinkam, S.P., and Geraci, M.W. (2006). MicroRNA in lung cancer. J. Thorac. Oncol. 1, 929-931. (Pubitemid 47181358)
27. O'Toole, A.S., Miller, S., Haines, N., Zink, M.C., and Serra, M.J. (2006). Comprehensive thermodynamic analysis of 3'doublenucleotide overhangs neighboring Watson-Crick terminal pairs. Nucleic Acids Res. 34, 3338-3344.
28. Park, J.S., Kim, K.M., Kim, M.H., Chang, H.J., Baek, M.K., Kim, S.M., and Jung, Y.D. (2009). Resveratrol inhibits tumor cell adhension to endothetial cells by blocking ICAM-1 expression. Anticancer Res. 29, 355-362.
29. Pillai, R.S., Bhattacharyya, S.N., and Filipowicz, W. (2007). Repression of protein synthesis by miRNAs: How many mechanisms? Trends Cell Biol. 17, 118-126. (Pubitemid 46357525)
30. Plasterk, R.H. (2006). Micro RNAs in animal development. Cell 124, 877-881. (Pubitemid 43344225)
31. Rana, T.M. (2007). Illuminating the silence: Understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell. Biol. 8, 23-36. (Pubitemid 46012012)
32. Revel, A., Raanani, H., Younglai, E., Xu, J., Rogers, I., Han, R., Savouret, J.F., and Casper, R.F. (2003). Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J. Appl. Toxicol. 23, 255-261. (Pubitemid 36950295)
33. Schneider, Y., Vincent, F., Duranton, B., Badolo, L., Gosse, F., Bergmann, C., Seiler, N., and Raul, F. (2000). Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett. 158, 85-91. (Pubitemid 30627485)
34. Soleas, G.J., Diamandis, E.P., and Goldberg, D.M. (1997). Resveratrol: A molecule whose time has come? And gone? Clin. Biochem. 30, 91-113. (Pubitemid 27180922)
35. Staudt, L.M., Dent, A.L., Shaffer, A.L., and Yu, X. (1999). Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6. Int. Rev. Immunol. 18, 381-403. (Pubitemid 29392083)
36. Stef, G., Csiszar, A., Lerea, K., Ungvari, Z., and Veress, G. (2006). Resveratrol inhibits aggregation of platelets from high-risk cardiac patients with aspirin resistance. J. Cardiovasc. Pharmacol. 48, 1-5. (Pubitemid 44358887)
37. Stervbo, U., Vang, O., and Bonnesen, C. (2006). Time-and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells. Cell Prolif. 39, 479-493. (Pubitemid 44760200)
38. Stewart, J.R., Artime, M.C., and O'Brian, C.A. (2003). Resveratrol: A candidate nutritional substance for prostate cancer prevention. J. Nutr. 133, 2440S-2443S. (Pubitemid 36828851)
39. Sun, C., Hu, Y., Liu, X., Wu, T., Wang, Y., He, W., and Wei, W. (2006). Resveratrol downregulates the constitutional activation of nuclear factor-kappaB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis. Cancer Genet. Cytogenet. 165, 9-19. (Pubitemid 43254647)
40. Zhang, B., Wang, Q., and Pan, X. (2007). MicroRNAs and their regulatory roles in animals and plants. J. Cell. Physiol. 210, 279-289. (Pubitemid 44956872)